Bullfrog AI

Bullfrog AI

Finding the link between therapies and patients

Print
View on Funders USA
Security Type
Crowd SAFE
Min Investment
$500
Location
Gaithersburg, MD
Offering Date
October 22, 2020
Expected Close Date
December 31, 2020
Target Raise
$25.00K-$1.07M

Company Description

BullFrog AI Holdings is an investor-backed company determined to become the undisputed leader in precision medicine. 

Our mission is to find the link between therapies and patients, and improve their lives. Using our proprietary technology platform, we aim to predict which patients will benefit from which medications, effectively improving clinical outcomes and eliminating the problem of trial-and-error prescriptions.

Use of Proceeds

  • Continued development
  • Pursue clinical projects
  • Grow Partnerships
  • Pursue biopharmaceutical companies
  • Hire core team members
  • Acquire rights to failed drugs
Amount Raised : $0
Reveal the Score by Voting
＿
Additional ratings from other users are needed to determine a viable CrowdScore for this deal.
The "CrowdScore" for this deal is determined by user ratings and other factors using our proprietary algorithm.
ⓘ
The overall viability and scalability of the business concept as well as the ability to drive the concept to profitability over time.
Business Idea
ⓘ
The progress made thus far in demonstrating that the business has viability, a customer base or other business traction.
Business Traction
ⓘ
The experience of the management team in running, scaling and/or exiting a business that required similar skills to execute the business plan.
Management Team
ⓘ
The value of the company compared to similar companies raising money from investors.
Valuation

Security Description

An equity crowdfunding specific version of a SAFE used by crowdfunding portal Republic. Upon conversion (if and when that happens), investors may receive special shares with limited rights that do not show up on a company’s cap table. The issuer may roll over and not convert shares at the next financing round causing investors to lose out on some upside.

Research Reports

No reports have been submitted

Become a Reporter
Read Our Research Disclaimer

0 Comments

Post Comment